TRIAL DETAIL

MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery

Drug:
Trial Name:
MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery
NCT#:
Conditions:
Sarcoma
Status:
Ongoing, but not recruiting
Phase:
2
Start Date 10/01/2010
Age of Trial (yrs) 11.9
Treatment Phase:
Gleevec-resistant
Drug Category:
mTOR inhibitor + MEK inhibitor
Strategy:
Trial Type:
GIST not specified. GIST patients known to be enrolled.
Other Protocol IDs:
CDR0000685408, CHNMC-PHII-95, NCCN-T06
Sponsor:
Beckman Research Institute,National Cancer Institute (NCI), National Comprehensive Cancer Network
Patient Contact:
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Oral Intravenous
Trial Notes:

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
9090 Wilshire Blvd
Beverly Hills
CA
90211
USA
1500 E. Duarte Road
Duarte
CA
91010
USA
Los Angeles
CA
90089
USA
Pasadena
CA
91105
USA
Hershey
PA
17033
USA
Pittsburgh
PA
15232
USA
4501 X St
Sacramento
CA
95817
USA